[BMJ] POS1129IN VITRO EVIDENCE DEMONSTRATES THAT AFIMETORAN (BMS-986256), AN EQUIPOTENT TLR7/8 DUAL ANTAGONIST, HAS STEROID-SPARING POTENTIAL IN THE CLINIC |
|
This post will be closed automatically in 2026-10-30 12:46
Reward10points
|
post
reply
points
910
50
[Full book]Puerarin alleviates atherosclerosis via the inhibition of Prevotella copri and its trimethylamine production
10
Men withFMR1premutation alleles of less than 71 CGG repeats have low risk of being affected with fragile X-associated tremor/ataxia syndrome (FXTAS)
10
POS1129IN VITRO EVIDENCE DEMONSTRATES THAT AFIMETORAN (BMS-986256), AN EQUIPOTENT TLR7/8 DUAL ANTAGONIST, HAS STEROID-SPARING POTENTIAL IN THE CLINIC
10
Common femoral artery access in emergency medicine
30
Endovascular therapy of acute vertebrobasilar occlusions: influence of first-line strategy in the Endovascular Treatment in Ischemic Stroke (ETIS) Registry
